Inhaled Nitric Oxide No Delivery System Market Size & Forecasts 2026-2035, By Segments (End User, Delivery System, Patient Population, Indication, Inhaled Nitric Oxide Concentration), Growth Opportunities, Innovation Landscape, Regulatory Shifts, Strategic Regional Insights (U.S., Japan, China, South Korea, UK, Germany, France), and Competitive Dynamics (Mallinckrodt, INO Therapeutics, Linde, Vero Biotech, Praxair)